Literature DB >> 23501351

[Impact of cancer treatments on cognitive functions: the patients' view, their expectation and their interest in participating to cognitive rehabilitation workshops].

Johan Le Fel1, Aurélie Daireaux, Sandrine Vandenbosshe, Natacha Heutte, Olivier Rigal, Katia Rovira, Florence Joly, Vincent Roy.   

Abstract

INTRODUCTION: Cancer and chemotherapy can have adverse effects on cognitive functions and quality of life of patients. We wanted to know the patients' view on these disorders, but also their expectations in terms of assessment and support. METHODS AND
RESULTS: A survey was conducted in day care hospital among 551 patients from three cancer centers. Most of the patients were between 40 and 74 years and suffered from breast cancer. Eighty-four percent were treated with chemotherapy. Forty-one percent of patients report memory problems, 26% were affected by specific concentration disorders, and 19% of the attention. On the whole, 52% of patients report at least one of the previous cognitive impairment. Among these patients, 80% evoked that the support of these problems was essential and 70% were willing to participate in "workshops" to deal with these disorders.
CONCLUSION: The cognitive impairment occurrence is a real problem for patients receiving chemotherapy and becomes a priority in the global management of their disease. Studies assessing a specific support of theses symptoms should be encouraged to help patients.

Entities:  

Keywords:  cancer; chemotherapy; cognitive disorders; rehabilitation

Mesh:

Substances:

Year:  2013        PMID: 23501351     DOI: 10.1684/bdc.2013.1710

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  Cognitive complaints in cancer survivors and expectations for support: Results from a web-based survey.

Authors:  Marie Lange; Idlir Licaj; Bénédicte Clarisse; Xavier Humbert; Jean-Michel Grellard; Laure Tron; Florence Joly
Journal:  Cancer Med       Date:  2019-03-18       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.